SQI Diagnostics: Funding, Investors & Team (Sep 2026)
SQI Diagnostics is a medical systems company that develops proprietary technologies in multiplexing, miniaturization and automation. They provide laboratories and clinical research organizations the ability to simultaneously analyze customized multiple biomarkers down to the isotype and subclass levels, deliver accurate and quantitative patient results in an IVD format in less time, significantly reduce labor and increase profits... All in One Drop.
SQI Diagnostics has raised $23.6M across 4 funding rounds on record, the most recent an undisclosed round of $10.0M announced in Mar 2023.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
SQI Diagnostics Company Profile and Key Stats
Latest funding round on record: Mar 2023.
SQI Diagnostics Funding Rounds
SQI Diagnostics raised $7.5M in a Post-IPO Debt announced in Apr 2022.
2 months later, a Post-IPO Debt of $4.1M was announced in Jun 2022.
5 months later, an undisclosed round of $2.0M was announced in Nov 2022.
4 months later, an undisclosed round of $10.0M was announced in Mar 2023.
SQI Diagnostics Founders and Leadership Team
Contact details for the SQI Diagnostics team: 2 of 2 have an email address on file.
Start 14-day free trial →SQI Diagnostics Funding Compared to Other Biotechnology Startups
SQI Diagnostics' latest round of $10.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like SQI Diagnostics in Biotechnology and Toronto
Companies Similar to SQI Diagnostics
Medicenna is a clinical-stage immunotherapy company focused on oncology and the development and…
Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective…
Hemostemix Inc. is a Canadian biotechnology company that specializes in creating blood-derived cell therapies…
Avicanna is an organization in the biopharmaceutical sector that concentrates on enhancing medical cannabis…
Edesa Biotech is a privately-held company in the clinical stage that specializes in creating therapies for…
ME Therapeutics is a biotech company that specializes in finding and creating drugs for immuno-oncology that…
Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and…
Medicus Pharma is a biotechnology research company that fast-tracks the progress of life sciences and…
ProteinQure is a biotechnology company specializing in creating innovative peptides for various medical…
Anodyne's mission is to create critical chemicals sustainably. Anodyne's approach takes advantage of nature's…
NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and…
ZYUS is a biopharmaceutical company focused on providing patients with cannabinoids and other plant-based…
SQI Diagnostics Funding FAQs
What does SQI Diagnostics do?
SQI Diagnostics is a medical systems company that develops proprietary technologies in multiplexing, miniaturization and automation. They provide laboratories and clinical research organizations the ability to simultaneously analyze customized multiple biomarkers down to the isotype and subclass levels, deliver accurate and quantitative patient results in an IVD format in less time, significantly reduce labor and increase profits... All in One Drop.
How much funding has SQI Diagnostics raised?
SQI Diagnostics has raised $23.6M across 4 rounds on record. The most recent is an undisclosed round of $10.0M announced in Mar 2023.
When did SQI Diagnostics last raise funding?
SQI Diagnostics' most recent funding round on record is an undisclosed round of $10.0M, announced in Mar 2023.
Who is the CEO of SQI Diagnostics?
Andrew Morris is listed as CEO at SQI Diagnostics.
Where is SQI Diagnostics headquartered?
SQI Diagnostics is based in Toronto, Ontario, Canada.
How many employees does SQI Diagnostics have?
SQI Diagnostics is in the 51-100 employee band.
How does SQI Diagnostics' funding compare to other Biotechnology startups?
SQI Diagnostics' latest round of $10.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's SQI Diagnostics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for SQI Diagnostics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.